The fragile X syndrome in a large family. I. Cytogenetic and clinical investigations. 1987

H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson

Cytogenetic and clinical investigations were performed in 85 members of a large family, in which 18 males and seven females were mentally retarded. In the male patients the fragile site Xq27 was found in 6 to 44% (mean 22.5%) of peripheral blood lymphocytes. One non-retarded male expressed the cytogenetic abnormality in 6% of his cells. In 21 females the fra(X) was found in 3 to 28% (mean 8.7%) of their cells. Two obligate carriers did not express the fragile site. A significant difference in expression between the seven retarded (mean 16.7%) and seven non-retarded female carriers of corresponding age (mean 6.3%) was found (alpha = 0.01). No significant correlation between expression and age could be established, either in males or in females. The cytogenetic results appeared to be consistent. To avoid false positives, a cut-off point was chosen: males were considered to be fra(X) negative if no more than one in 100 cells showed the abnormality; for females the cut-off point was two in 100 cells. Segregation analysis did not detect significant deviations from the expected ratios. The putative presence of a transmitting male is discussed. The results of recombinant DNA analysis will be published elsewhere. Clinical investigations confirmed the findings of others. CT scans showed an enlargement of the ventricular system that exceeded the expected age changes.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D002871 Chromosome Banding Staining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping. Banding, Chromosome,Bandings, Chromosome,Chromosome Bandings
D005260 Female Females
D005600 Fragile X Syndrome A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226) FRAXA Syndrome,FRAXE Syndrome,Martin-Bell Syndrome,Fra(X) Syndrome,Fragile X Mental Retardation Syndrome,Fragile X-F Mental Retardation Syndrome,Mar (X) Syndrome,Marker X Syndrome,Mental Retardation, X-Linked, Associated With Fragile Site Fraxe,Mental Retardation, X-Linked, Associated With Marxq28,X-Linked Mental Retardation and Macroorchidism,FRAXA Syndromes,FRAXE Syndromes,Fragile X Syndromes,Marker X Syndromes,Martin Bell Syndrome,Syndrome, FRAXA,Syndrome, FRAXE,Syndrome, Fragile X,Syndrome, Marker X,Syndrome, Martin-Bell,Syndromes, FRAXA,Syndromes, FRAXE,Syndromes, Fragile X,Syndromes, Marker X,X Linked Mental Retardation and Macroorchidism
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson
March 1998, Arquivos de neuro-psiquiatria,
H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson
January 1990, European neurology,
H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson
October 1989, Tijdschrift voor kindergeneeskunde,
H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson
January 1986, Indian journal of pediatrics,
H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson
July 1987, Journal of medical genetics,
H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson
June 1992, Zeitschrift fur Kinder- und Jugendpsychiatrie,
H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson
January 1992, Polski tygodnik lekarski (Warsaw, Poland : 1960),
H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson
July 1990, Journal of medical genetics,
H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson
November 1984, Chinese medical journal,
H Veenema, and J P Geraedts, and G C Beverstock, and P L Pearson
November 1988, American journal of human genetics,
Copied contents to your clipboard!